Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuto Inoue

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Calcium|March 25, 2017
[The Discovery, Research and Development of Etelcalcetide Hydrochloride, the World 1st Intravenous Calcimimetics.]Atsuto Inoue, Kazutsune Harada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 11, 2017
The pharmacological profile and the clinical efficacy of the world's 1st intravenous calcimimetics; etelcalcetide hydrochloride (Parsabiv<sup>®</sup>)Kazutsune Harada, Atsuto Inoue, Akinori Yamauchi, et al.
European Journal of Pharmacology|October 22, 2018
Pharmacology of Parsabiv<sup>®</sup> (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patientsKazutsune Harada, Aiko Fujioka, Masakazu Konno, et al.
Biochemical and Biophysical Research Communications|February 19, 2003
Molecular cloning and characteristics of a novel zinc finger protein and its splice variant whose transcripts are expressed during spermatogenesisMasamichi Ishizuka, Hirotaka Ohshima, Norihisa Tamura, et al.
Molecular and Cellular Endocrinology|February 14, 2006
Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2Rong-Hua Tao, Hisaya Kawate, Yin Wu, et al.
Congenital Anomalies|November 6, 2015
Using zebrafish in systems toxicology for developmental toxicity testingYuhei Nishimura, Atsuto Inoue, Shota Sasagawa, et al.
Bioorganic & Medicinal Chemistry|March 25, 2015
Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acidSatoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
Journal of Bone and Mineral Metabolism|October 13, 2020
Effect of etelcalcetide on parathyroid hormone secretion by primary hyperparathyroidism patient-derived primary parathyroid cellsAiko Fujioka, Yasuo Imanishi, Ikue Kobayashi, et al.
Journal of Bone and Mineral Metabolism|November 16, 2020
Etelcalcetide decreases the PTH-calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidismNoriyuki Hayashi, Yasuo Imanishi, Tomoe Hirakawa, et al.
Development, Growth & Differentiation|July 8, 2016
Abnormal spermatogenesis and male infertility in testicular zinc finger protein Zfp318-knockout miceMasamichi Ishizuka, Eri Ohtsuka, Atsuto Inoue, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Calcium|March 25, 2017
[The Discovery, Research and Development of Etelcalcetide Hydrochloride, the World 1st Intravenous Calcimimetics.]Atsuto Inoue, Kazutsune Harada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 11, 2017
The pharmacological profile and the clinical efficacy of the world's 1st intravenous calcimimetics; etelcalcetide hydrochloride (Parsabiv<sup>®</sup>)Kazutsune Harada, Atsuto Inoue, Akinori Yamauchi, et al.
European Journal of Pharmacology|October 22, 2018
Pharmacology of Parsabiv<sup>®</sup> (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patientsKazutsune Harada, Aiko Fujioka, Masakazu Konno, et al.
Biochemical and Biophysical Research Communications|February 19, 2003
Molecular cloning and characteristics of a novel zinc finger protein and its splice variant whose transcripts are expressed during spermatogenesisMasamichi Ishizuka, Hirotaka Ohshima, Norihisa Tamura, et al.
Molecular and Cellular Endocrinology|February 14, 2006
Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2Rong-Hua Tao, Hisaya Kawate, Yin Wu, et al.
Congenital Anomalies|November 6, 2015
Using zebrafish in systems toxicology for developmental toxicity testingYuhei Nishimura, Atsuto Inoue, Shota Sasagawa, et al.
Bioorganic & Medicinal Chemistry|March 25, 2015
Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acidSatoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
Journal of Bone and Mineral Metabolism|October 13, 2020
Effect of etelcalcetide on parathyroid hormone secretion by primary hyperparathyroidism patient-derived primary parathyroid cellsAiko Fujioka, Yasuo Imanishi, Ikue Kobayashi, et al.
Journal of Bone and Mineral Metabolism|November 16, 2020
Etelcalcetide decreases the PTH-calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidismNoriyuki Hayashi, Yasuo Imanishi, Tomoe Hirakawa, et al.
Development, Growth & Differentiation|July 8, 2016
Abnormal spermatogenesis and male infertility in testicular zinc finger protein Zfp318-knockout miceMasamichi Ishizuka, Eri Ohtsuka, Atsuto Inoue, et al.
Pageof 2